Market Place
Sourcing Support
Lubrizol, Polyhose Ink MoU for Medical Tube Facility in Tamil Nadu
16 Nov 2024 //
INDPHARMAPOST
Lubrizol Opens Beauty Research Institute in Shanghai, China
27 Aug 2024 //
BUSINESSWIRE
Lubrizol: LIPOFER™ Technology Showcase, EU Approval for Carbopol®
08 May 2024 //
BUSINESSWIRE
Lubrizol`s Apisolex™ Polymer Wins Finished Formulation Award at CPhI Barcelona
25 Oct 2023 //
BUSINESSWIRE
Lubrizol’s Apisolex™ Polymer Wins Finished Formulation Award at CPhI Barcelona
25 Oct 2023 //
BUSINESSWIRE
Lubrizol Launches Carbopol® Polymers for Nutraceuticals
23 Oct 2023 //
BUSINESSWIRE
Lubrizol Licenses Award-Winning Apisolex™ Excipient to Welton Pharma
20 Jun 2023 //
BUSINESSWIRE
Lubrizol Showcases Plant-based Iron-Fortified Gummies
25 Apr 2023 //
PR NEWSWIRE
Lubrizol’s Apisolex Technology Voted Grand Winner of the Innovation Award
06 Apr 2023 //
PRESS RELEASE
Lubrizol Reveals Insights-Driven, Consumer-Led Nutra 2.0 Strategy
29 Mar 2023 //
PR NEWSWIRE
How to Select the Right CDMO for Your Sterile Drug Product
13 Dec 2021 //
CONTRACTPHARMA
A Guide to Vaccine Development from Lubrizol Life Science
19 Jan 2021 //
CONTRACTPHARMA
Lubrizol Life Science Launches Advanced, Natural Nutraceutical Solution
28 Oct 2020 //
PRNEWSWIRE
Lubrizol Expands Partnership with the Population Council
22 Oct 2020 //
CONTRACTPHARMA
Lubrizol Supports Women’s Health Worldwide
16 Sep 2020 //
CONTRACTPHARMA
Particle Sciences becomes Lubrizol Life Science Health
05 Nov 2019 //
PRESS RELEASE
Lubrizol Acquires Bavaria Medizin Technologie GmbH
16 Jul 2019 //
CONTRACT PHARMA
Hoth Therapeutics to Begin Production of BioLexa Therapeutic
10 Jun 2019 //
PR NEWSWIRE
Particle Sciences Expands Controlled Substance Capabilities
29 May 2019 //
CONTRACT PHARMA
Particle Sciences Invests in Commercialization Expertise
26 Mar 2019 //
GLOBENEWSWIRE
Particle Sciences receives patent to deliver medication to tympanic membrane
02 Aug 2018 //
DRUG DELIVERY BUSINESS
CDMO Particle Sciences making leap to commercial production
14 Jun 2017 //
FIERCE PHARMA
Lubrizol invests $60m in drug production at Particle Science plant
13 Jun 2017 //
IN PHARMATECHNOLOGIST
Glenmark, Particle Sciences to develop generic cancer drug
19 Sep 2016 //
ECONOMICTIMES
Excipients Market by Tropical, Parenteral & Other Routes of Administration
04 Aug 2016 //
PR NEWSWIRE
Excipients Market to Reach US$626.9 Million by 2023
17 May 2016 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.